Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis

Journal of Infectious Diseases

Volumn 161, Issue 5, 1990, Pages 988-991

  Pisa, Pavel ^a,b   Gennene, Mengistu ^a,b   Söder, Olof ^a,b   Ottenhoff, Tom ^a,b   Hansson, Mona ^a,b   Kiessling, Rolf ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST RESISTANCE; HUMAN; LEISHMANIA AETHIOPICA; LEISHMANIASIS; LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PROTOZOON; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; FEMALE; HUMAN; IMMUNITY, CELLULAR; LEISHMANIASIS; LEISHMANIASIS, VISCERAL; LEPROSY; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0025342458     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/161.5.988     Document Type: Article

References (31)

1. Beutler B., Cerami A., Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986;320:584–588
2. Peters P.M., Octaldes J.R., Shalaby M.R., Svedersky L.P., Nedwin G.E., Bringman T.S., Hass P.E., Aggarwal B.B., Herberman R.B., Goeddel D.Y., Palladino M.A., Natural killer sensitive targets stimulate production of TNF–α but not TNF–γ (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol 1986; 137: 2592–2598
3. Cuturi M.C., Murphy M., Costa-Giomi M.P., Weinmann R., Perussia B., Trinchieri G., Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987;165:1581–1594
4. Shalaby M.R., Aggarwal B.B., Rinderknecht E., Svedersky L.P., Finkle B.S., Palladino M.AJr., Activation of human polymorphonuclear neutrophil functions by interferon–γ and tumor necrosis factor. J Immunol 1985;135:2069–2073
5. Gamble J.R., Harlan J.M., Klebanoff S.J., Vadas M.A., Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82:8667–8671
6. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., Waitersdorph A.M., Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986;136:4220–4225
7. Djeu J.Y., Blanchard D.K., Halkias D., Friedman H., Growth of Candidaalbicans by human polymorphonuclear neutrophils: activation by interferon-y and tumor necrosis factor. J Immunol 1986;137:2980–2984
8. Silberstein D.S., David J.R., Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 1986;83:1055–1059
9. Nawroth P.P., Bank I., Handley D., Cassimeris J., Chess L., Stern D., Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986;163:1363–1375
10. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., Mundy G.R., Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986;319:516–518
11. Saklatvala J., Tumor necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547–549
12. Libby P., Ordovas J.M., Auger K.R., Robbins A.H., Birinyi L.K., Dinarello C.A., Endotoxin and tumor necrosis factor induce interleukin–1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986;124:179–185
13. Munker R., Gasson J., Ogawa M., Koeffler H.P., Recombinant human TNF induces production of granulocyte–monocyte colony–stimulating factor. Nature 1986;323:79–82
14. Dayer J.M., Beutler B., Cerami A., Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163–2168
15. Trinchieri G., Kobayashi M., Rosen M., Louden R., Murphy M., Perussia B., Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 1986;164:1206–1225
16. Mestan J., Digel W., Mittnacht S., Hillen H., Blohm D., Moller A., Jacobsen H., Kirchner H., Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 1986;323:816–819
17. Taveme J., Tavernier J., Fiers W., Playfair J.H.L., Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol 1987;67:1–4
18. Waage A., Halstensen A., Espevik T., Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355–357
19. Tracey K.J., Fong Y., Hesse D.G., Monogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A., Anti–cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662–664
20. Beutler B., Cerami A., Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988;9:57–66
21. Scuderi P., Lam K.S., Ryan K.J., Petersen E., Sterling K.E., Finley P.R., Ray C.G., Slymen D.J., Salmon S.E., Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986;2:1364–1365
22. Bryceson A.D.M., Diffuse cutaneous leishmaniasis in Ethiopia. III. Immunological studies. Trans R Soc Trop Med Hyg 1970;64:380–393
23. Godal T., Leprosy immunology–some aspects of the role of the immune system in the pathogenesis of disease. Lepr Rev 1984;55:407–414
24. Ridley D.S., Jopling W.H., Classification of leprosy according to immunity. A five–group system. Int J Lepr Other Mycobact Dis 1966; 34:255–273
25. Rouzer C.A., Cerami A., Hyperglycidemia associated with Trypanosomabrucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol 1980;2:31–38
26. Schurr E., Kidane K., Yemaneberhan T., Wunderlich F., Cutaneous leishmaniasis in Ethiopia: 1. Lymphocyte transformation and antibody titer. Trop Med Parasitol 1986;37:403–408
27. Akuffo H., Schurr E., Andersson G., Yamaneberhan T., Britton S., Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences. Scand J Immunol 1987;26:717–721
28. Barnetson R.S., Bjune G., Pearson J.M.H., Kronvall G., Cell mediated and humoral immunity in “reversal reactions.” Int J Lepr Other Mycobact Dis 1976;44:267–274
29. Sherman M.L., Spriggs D.R., Arthur K.A., Imamura K., Frei E. III, Kufe D.W., Recombinant human tumor necrosis factor administered as a five–day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 1988;6:344–350
30. Peetre C., Thysell H., Grubb A., Olsson I., A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988;41:414–419
31. Seckinger P., fsaaz S., Dayer J.M., A human inhibitor of tumor necrosis factor α. J Exp Med 1988;167:1511–1516